>
pdufa.bio

Darovasertib

Updated ยทnext FDA decision on the calendar

Darovasertib is a IDEAYA Biosciences, Inc. program. Its next catalyst is a Readout in Jan 2027. Every date links its source.

IDYA catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: IDEAYA Biosciences, Inc. (IDYA). We track 2 catalyst events for this program: 2 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jan 2027IDYAReadout · Apr 2027IDYA

Questions

When is Darovasertib's next FDA decision or readout?

The next tracked catalyst for Darovasertib is a Readout in Jan 2027.

What happened at Darovasertib's most recent FDA decision?

No FDA decision for Darovasertib is in our archive yet.

Who makes Darovasertib?

IDEAYA Biosciences, Inc. (IDYA).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.